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Abstract 
Objective: Black men are three times more likely to develop prostate cancer (PCa), to do so 
at a younger age and to experience a more aggressive form than White men. This study 
aims to understand the experiences of African-Caribbean men with respect to their discharge 
to primary care following successful PCa treatment and the challenges associated with 
survivorship.  
Design: Eight African-Caribbean men, who had been successfully treated for PCa, were 
recruited through the charity BME Cancer Communities. They participated in a focus group, 
which took place on the premises of the charity and was audio-recorded. The recording was 
transcribed and the data were analysed employing thematic analysis.   
Results: Three overarching themes were developed: Discharge - misconceptions and 
uncertainties; Survivorship - challenges and ways of coping; Black men and PCa: real and 
potential discrimination. Participants expressed concerns regarding the lack of information 
and clarity about what discharge meant, the quality of follow-up care, especially the levels of 
specialist knowledge among GPs, and the impact of side-effects, particularly erectile 
dysfunction (ED). Participants linked ED with stereotypes of Black male sexuality, particularly 
in relation to difficulties of expressing their emotions and psychological distress. African-
Caribbean men face particular challenges in dealing with the side-effects of treatment for 
PCa, which are linked to socially-constructed ideas of masculinity.  
Conclusion: There needs to be a greater focus in primary care on understanding these 
issues and providing individualised culturally-sensitive care. In particular, GPs should be 
aware of sensitivities concerning help-seeking related to culturally-mediated understandings 
of masculinity. 
Keywords: prostate cancer; discharge; Black men; follow-up; cancer survivorship; primary 
care 
 
 
3 
 
Introduction 
Prostate cancer (PCa) is the most common cancer in men in the United Kingdom 
(UK) and constitutes a quarter of all new cases of cancer among males. There are 
approximately 47,700 new PCa cases in the UK every year (Cancer Research UK [CRUK] 
2018). It is uncommon before the age of 50 but increases rapidly thereafter. There were 
11,631 deaths in the UK from PCa in 2016 (CRUK 2018) and it is a global health concern.   
There are important ethnic variations in the incidence, progression and outcomes of 
PCa. Most notably, Black African and African-Caribbean1 men have incidence rates 
approximately 2-3 times those of White (Caucasian) men (Pedersen, Armes, and Ream 
2012). The first UK-based multicentre, population-based study comparing PCa incidence 
rates of Black and White men reported that Black African and Black Caribbean men were 
three times more likely to be diagnosed with PCa than White men (Ben-Shlomo et al. 2008). 
They tend to develop the disease at an earlier age than White men (Shenoy et al. 2016) and 
in a more aggressive form (Powell et al. 2010). Improved survivorship rates across a range 
of cancers have prompted interest in the experiences of survivors, including in relation to 
their return to primary care services. In the UK in 2011 the one-year survival rate for PCa 
was 94% and the five-year rate was 84.8%. These survival rates were the highest among the 
21 most common cancers in the UK (CRUK 2018). 
 Virtually all treatments for PCa, both localised and metastatic, are associated with 
significant side-effects (Siegel et al. 2012; Lavery and Cooperberg 2017).  Men's responses 
to these are determined in great part by culturally determined norms of masculinity and this 
can result in challenges to men's masculine self-image, particularly in response to impacts 
on sexual function and urinary continence (Chambers et al. 2016). Most survivors of PCa 
                                                 
1 We recognise that there are important cultural and other differences between groups of members described as "Black".  
The participants in this study self-described in this way and for simplicity, this term has been employed throughout this 
paper except when referring to the findings of particular studies. 
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(PCaSs) report long-term treatment side-effects, including ED but Matthews et al. (2012) 
found that, compared with White patients, Black men had significantly poorer physical and 
emotional functioning after their treatment. The latter has been linked with feelings of 
embarrassment and shame associated with urinary, sexual and bowel dysfunction (Zaider et 
al. 2012) 
Rivers et al (2011) reported that Black men rarely discussed sexual dysfunction with 
their spouses, indicating that an unwillingness to speak openly about these matters might be 
a barrier to seeking medical help. Guidance from the National Institute for Health and Clinical 
Excellence (NICE) (2014) suggests that patients with a stable PSA2 level at least 2 years 
after the completion of their radical treatment for PCa and patients who are undergoing 
“watchful waiting”3 should be discharged and offered follow-up care in primary care settings.  
A number of studies have identified issues in relation to the cancer-specific knowledge of 
Primary Care Physicians (PCPs) (known as General Practitioners [GPs] in the UK). For 
example, a US cross-sectional survey of cancer survivors (Nyarko et al. 2015) reported that 
43% perceived their PCP as knowledgeable about cancer follow-up and 45% viewed them 
as knowledgeable about late or long-term effects of cancer therapy. Although it did not 
address issues in primary care, an analysis of UK National Health Service (NHS) cancer 
patient satisfaction that focused specifically on respondents from minority ethnic groups 
found that they reported statistically significantly lower levels of satisfaction with care and 
with their communication with healthcare professionals compared with those from the 
majority White population (Pinder, Ferguson and Moller 2016).   
However, this analysis did not specifically examine the experiences of Black men with 
PCa that might explain their comparatively lower satisfaction rating. A report by the charity 
                                                 
2 Blood tests for Prostate Specific Antigen (PSA) carried out to detect increases in PSA, which can indicate the 
presence of PCa. 
3 Watchful waiting is offered for asymptomatic PCa to avoid treatment side-effects, is more suitable for men with 
comorbidities, and involves regular follow-up in primary care (Prostate Cancer UK 2016). 
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Black and Minority Ethnic (BME) Cancer Communities (Thompson 2013) highlighted both a 
lack of cultural competence amongst healthcare professionals and a lack of cancer 
awareness in Black communities as likely contributors to poor outcomes from PCa in Black 
men. Bamidele et al. (2018) carried out a systematic review of the post-treatment 
experiences of Black African and Black Caribbean men with PCa. They reviewed four 
qualitative studies published between 2005 and 2013; three based on a UK sample and one 
on a Canadian sample. Across the studies, men discussed the impact of treatment side-
effects on sexual activity, their involvement in decision-making concerning treatment, their 
experiences of healthcare and communication with healthcare professionals as well as a 
range of other issues. Many of the comments related to experiences with secondary care 
professionals and there was little about primary care or the experience of discharge.  
There continues to be a shortage of evidence about the experiences, knowledge and 
beliefs of Black men in the UK concerning side-effects, survivorship and sources of 
information and support following successful treatment for PCa and discharge back to 
primary care. A number of recent studies (e.g. Nanton and Dale 2011; Anderson, Marshall-
Lucette, and Webb 2013) have addressed issues relating to cancer and PCa survivorship 
and masculinity in Black men, but this study differs from them in some important respects. 
Those studies focused on a wide range of issues such as pre-diagnostic knowledge, 
treatment-related decision-making, survivorship, risk perceptions and screening but did not 
address the experience of follow-up in primary care.  
Previous research has reported concerns among mixed groups of cancer patients 
(including men with PCa) who had been discharged to primary care following treatment 
(Harrison et al. 2012; Hudson et al. 2012). The current study aimed to investigate specifically 
this experience among African-Caribbean men in the UK and sought to answer the following 
questions: 
• What are the experiences of Black men with respect to their follow-up in primary 
care after successful PCa treatment? 
• What are the challenges faced by Black men in the transition to survivorship? 
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In attempting to answer these questions we will draw on the concepts of hegemonic 
masculinity and intersectionality. The term hegemonic masculinity (Courtenay 2000) refers to 
institutionalised and culturally dominant representations of particular ways of being a man 
that emphasise physical dominance and toughness, emotional reticence and sexual 
prowess. It is not necessarily the only possibility for being a man, but it is a standard against 
which other versions of masculinity are evaluated. Scott-Samuel, Stanistreet and Crawshaw 
(2009) argued that hegemonic masculinity can act to establish social and political 
relationships that are harmful to the health of men and women. The concept of 
intersectionality was developed by Crenshaw (1989) and is increasingly used to facilitate 
understanding of how factors such as gender, race and socioeconomic status interact to 
determine inequalities in health outcomes (Kapilashrami, Hill, and Meer 2015). Together 
these concepts provide a useful framework for examining the experiences of Black men. 
Method 
Research design 
  To address hegemonic masculinity and intersectionality as they apply to Black men 
we adopted a qualitative approach based on focus group methodology with Black PCaSs. 
Qualitative research methods enable an in-depth understanding of the experiences and 
feelings of research participants and the significance of these experiences to them (Sullivan, 
Gibson, and Riley 2012).  
Men recruited to the study (see below) were familiar with speaking openly about PCa 
in a group setting, so the approach was consistent with their previous experience. A focus 
group drawing on pre-existing groups (i.e. support groups) allows an interpersonal interaction 
that is more realistic and natural because participants feel comfortable commenting on each 
other’s experiences and expressing their own views (Krueger and Casey 2014), particularly 
in relation to sensitive topics such as sexuality and ED. This permits spontaneous 
interactions and responses, thereby generating rich data in a short time period (Krueger and 
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Casey 2014; Then, Rankin, and Ali 2014). 
Focus group methodology is widely used for examining people’s understanding of 
illness and health behaviours and experiences of health services (Bowling 2014; Odedina et 
al. 2004). 
 
Recruitment procedure and participants’ characteristics 
The inclusion criteria stipulated that participants be Black African or African- 
Caribbean men, under 75 years old who had been successfully treated for localised PCa and 
were attending their GP for post-treatment follow-up. The age-range was based on the need 
to examine the impact of the side-effects of treatment while reducing the likelihood of 
comorbidities. There were no exclusion criteria.  
Participants were recruited through a convenience sampling strategy from Friends 
and Bredrins (F.A.B.), a support group in Nottingham organised by the charity BME Cancer 
Communities (BMECC) aimed at African-Caribbean men and their families in the East 
Midlands region of the UK. We employed this approach because of difficulties in identifying 
participants based on NHS records.  Access to the group was facilitated by the Chair of 
BMECC.  Current members of the group were approached by the Chair and asked to 
participate; all agreed. No financial or other incentives to participate were offered. 
 
Ethical considerations 
Ethical approval for the study was obtained from the University of East London 
Research Ethics Committee. All participants were provided in advance with an information 
sheet giving details of the study and their right to withdraw and completed a consent form at 
the start of the focus group. Ground rules were developed in conjunction with participants, 
which covered issues such as confidentiality, respect for the views of others and allowing 
participants to speak without interruption.   
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Data collection 
The focus group was facilitated by the first author. The topic guide was developed in 
consultation with staff of BMECC and covered a range of issues, including the process of 
discharge from hospital-based care, anxieties about discharge, the side-effects of treatment 
and the support they received in connection with these, their experiences of GP care and the 
challenges of life as a survivor (see Table 1 for a sample of interview questions). The focus 
group lasted 90 minutes and was audio recorded. The researcher kept field notes. The field 
notes enabled reflection on the researcher’s experience as a facilitator, her facilitative skills 
and her influence on the researcher-participant relationship. 
The recording was transcribed by the first author employing the semantic-level 
approach advocated by Banister (2011). Participants were given pseudonyms to ensure 
anonymity. (INSERT TABLE 1 ABOUT HERE) 
 
Data analysis 
 Data were analysed inductively by the first author using thematic analysis, a 
qualitative method that identifies, describes and reports themes within the data (Braun and 
Clarke 2006). The stages of analysis outlined by Braun and Clarke (2006) were followed, 
including familiarisation with the data by repeated reading, the generation of initial codes and 
combining these into themes based on shared features. Each individual transcript was read 
and re-read and data were coded. These codes were then grouped into 
potential themes which were reviewed, refined and named in conjunction with the other 
authors. Developing themes were checked against the constituent codes and linked 
quotations in order to ensure fidelity to the data while following an interpretative approach. 
Theme development ceased when the existing themes captured the codes.   
In order to ensure the quality of the study, we drew on the criteria outlined by Tracy 
(2010), including the importance of the topic, the rigour of the analytic process, transparency 
concerning procedures and the contribution of the study. Verbatim transcription was followed 
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by rigorous data analysis that permitted the transformation and organization of the data into 
themes enabling meaningful claims to be made. 
Results 
A total of 8 participants was recruited and the focus group was conducted on BMECC 
premises. Table 2 shows the key demographic characteristics of the participants regarding 
their age, relationship and employment status. All the participants self-identified as African-
Caribbean and the majority was married or had a partner. Their ages ranged from 51 to 75 
years. (INSERT TABLE 2 ABOUT HERE) 
The following main themes were identified from the data; 1) Discharge - 
misconceptions and uncertainties, 2) Survivorship - challenges and ways of coping and 3) 
Black men and PCa: real and potential discrimination. Table 3 shows the main themes and 
their sub-themes developed in the analysis. (INSERT TABLE 3 ABOUT HERE) 
 
1. Discharge: misconceptions and uncertainties 
 The meaning and consequences of discharge from secondary to primary care were viewed 
as unclear.  Participants described a lack of information and a lack of clarity about what 
discharge actually meant and the role of the GP. They reported feeling insecure and 
uncertain about care in the future.  
‘Well, it’s (discharge) a very common phrase that they use, and they mean that 
“we’ve done basically what we can, you had your operation, and you had your radiotherapy 
and now we will discharge you back to your GP”... And you’ve got to make your own 
conclusion what the GP is all about.’ (P2, 71)4 
                                                 
4Each quote is presented with the participant’s identifying pseudonym and age. 
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‘They don’t say that “you will go to your GP and you have to do this and that”, they 
just say “we will discharge you back to your GP” and you think “wow is the service is going to 
be the same as I am getting here?” (P4, 59) 
All agreed that there is a common misconception that discharge means cancer has 
been cured. P5 explained that there is a lack of information about the risk of recurrence and 
the importance of follow-up care.  
‘Well, you know it is not like “Ok, I am discharging you, you can go back to your GP 
but you can still get it again, it can still come back”, it’s not like that, they don’t tell you that. I 
know that this is not a good thing for them to tell you or they could just say that there is a 
possibility but you go to your GP and you think “oh yes great! So, they never tell you the 
seriousness of what might happen next.’ (P5, 75) 
P2 stated that ‘the discharge means nothing’ to him. He explained that 
misunderstanding the nature of discharge could be dangerous and emphasised the 
importance of men being properly informed. Some men, such as P7, were offered a choice 
between being followed up by the hospital or the GP. He explained that he chose hospital-
care because he did not trust the GP in this context.  
‘They gave me a choice “would you like the hospital to contact or your doctor?” and to 
me it makes sense the results and everything be taken care of the hospital and why to go to 
the doctors and then feel like “oh my god he lost my notes” or the doctor may forget and I felt 
more comfortable with the hospital sending me a reminder and going to the hospital and 
those people take blood more regularly’ (P7, 67) 
All participants were concerned about the level of expertise and resource issues in 
primary care.  
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‘And you think “wow is the service going to be the same as I am getting here (in the 
hospital)?” and you know that the service is not gonna be the same because that’s a hospital 
and that’s a general practitioner.’ (P4, 59) 
‘They don’t have enough information, they just don’t know. I think it is about time and 
resources, isn’t it?’ (P6, 64) 
Participants were frequently concerned about continuity of care in general practice, 
believing that it could be easier to raise potentially difficult topics with a familiar GP or with a 
female GP. 
‘Yes, that’s true in a health centre it is very, very hard to see the same doctor all the 
time and you don’t have this familiarity and you don’t feel comfortable to say or mention 
something (…) if you have a preference to see the doctor you want to see, it is more difficult. 
I may feel better speaking to a woman, and you can’t get to see who you want.’ (P7, 67) 
Concerns about the side-effects of treatment and the expertise of the GP in 
addressing them were also important. 
‘I spent a bit more time with them (hospital specialists) and I explained more things in 
more depth so when I didn’t have the answers from GPs or I felt that I wasn’t given enough 
information (…) because of the consultant’s expertise who is specialised especially in erectile 
dysfunction, that was his speciality whereas you get a GP who looks at everything and they 
are not specialised in that particular area.’  (P5, 75) 
 
2. Survivorship:  challenges and ways of coping  
There were two aspects to this theme. One concerned the process of dealing with the 
long-term side-effects of treatment and difficulties in obtaining help and support for these. 
The other was related to the challenges in managing information within their families.  
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2a. Dealing with the long-term side-effects of treatment and difficulties in obtaining help and 
support for these. 
 
 All agreed that there was a lack of support regarding the psychological aspects of the side-
effects.  
‘I am going to my GP every 6 months to have my PSA but ... no one asked me “how 
are the things with you? How you are feeling?” there is no occasion about that and I am 
going through this since 2008.’ (P1, 55) 
Following diagnosis and treatment initial concerns focused on survival, but once the 
immediate crisis was past the side-effects became more salient, particularly as old routines 
were re-established.  
‘The first thing is “I don’t want to die” and then the second thing is “I’ve to get it 
(cancer) out” and then you don’t think about anything else until you get the operation and 
then after the operation, you just care if it is a success and then after that then the side-
effects start kicking you because now you want to start to do what you used normally to do.’ 
(P4, 59) 
Urinary incontinence was common in the group but generally considered a relatively 
minor inconvenience.  
‘Well the thing with me is that I am OK but I could still have incontinence when I am 
work or if I am at the gym, but apart from that I am fine.’ (P8, 73) 
 All participants agreed that the biggest challenge after treatment was their sex life 
and gave accounts of how for some men they knew, sexual potency was more important 
than surviving.  
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‘When you can’t perform sexually, you will think “Oh my God what I will do?” so he 
feels a failure and he doesn’t try anything else and that’s a shame really because the 
psychological part is a killer as well.’ (P4, 59) 
‘Some men said to me "I'd rather be dead than live without sex", that's some people's 
mindset, their personality’ (P8, 73) 
For some men, the loss of a body part was a source of distress and required a period of 
adjustment.  
‘The psychological thing for me was the removal of the prostate, not the sexual thing 
because someone was taking something out of me when I think about it, I feel like this is part 
of me, that's been taken away.’ (P5, 75) 
The support group was seen to fill the gap in the service provision and was described 
as an ‘after-care service’ (P5, 75) that provided ‘a sort of counselling’ (P2, 71). All agreed 
that the support group was the most significant source of help and support, describing it as a 
safe place where they could find information, comfort, exchange thoughts and be open about 
their concerns and worries. 
‘There are so much knowledge and information and you feel so comfortable around 
the group because you know that they've gone through similar and you have that degree of 
understanding as well, cause your people can be understanding at a certain level but they 
have not been through it, you know.’ (P4, 59) 
 
2b. Challenges in managing information within the family 
While these men desired psychological support from services and valued the group 
as a place they could share their feelings, several described how they often had to hide 
feelings at home. This happened for a number of reasons.  P7 felt that he had to present a 
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strong role model for his sons in case they developed PCa in the future, explaining that he 
had to remain strong and calm for them so it would be easier and less stressful for them.  
‘I’ve got two sons and I can see that both of them handle my situation differently so I 
have to be careful at the same time, how they perceive me, how my treatment goes, how I 
am handling, because they will see how they would handle it, how dad was handling it so if  I 
am gonna pass it to them, they may get it so I’ve got to put them in a position that they will 
feel safe and secure, and if it is necessary to have the operation themselves, not worry about 
the side-effects and remember how bad their dad was.’ (P7, 67) 
There was also a desire to protect their families from further anxiety about them. 
‘I don’t talk about it with my kids. They got too much to deal with, I talk to my wife, she 
is my soulmate, the person who understands me but for the rest of my family they say “dad 
are you ok?” and I say yes. But I don’t discuss that.’ (P2, 71). 
‘I think most people because you know by telling them everything, by telling your kids, 
your partner, your wife everything, it puts them in a state of worry and I mean, if you don't tell 
them everything, they think you are reasonably ok. But if you tell them everything, then it is 
another worry for them “oh my god why he is leaking again? He is going to the toilet because 
he is leaking, not because he wants to go to the toilet” so I just avoided that and I kept a 
balance.’ (P5, 75) 
 
3. Black men and PCa: real and potential discrimination 
 There was a consensus that the lack of knowledge among GPs regarding the greater 
risk of PCa in African-Caribbean men could lead to discrimination and inadequate provision 
of health care services and support.  
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‘The GPs probably whether they are not aware or they won’t admit and treat, you 
know, Black men as an actual special case given the statistics.  In other words, from them to 
be more aware and more informed about the risk, the increased risk of PCa in Black men so 
when they have Black men as patients, and  when they reach a particular age, 50 or 
whatever it may be, they should be aware of considering, you know, to refer them and  tell 
them to do a PSA test to start with or be more aware that they could have PCa and I think 
this is a problem with the GPs, not be  aware of that as much. It’s not actually 
miscommunication, it is probably lack of information.’ (P6, 64) 
Some men believed that racial stereotypes might make it difficult for African-Caribbean men 
to disclose their sexual problems to their doctors and ask for help or support.  
‘I think there is a perception that Black men they supposed to be sexual human 
beings and that every Black man is a sex icon, which is a lot of rubbish.  So, having that 
stereotype running around, that’s probably why some of the men are afraid to talk openly 
because they have this image to live up to. I mean, I am in the gym, in the shower, and the 
other guys say “Oh I bet you have 3 women”. Hold on a minute, what does that mean? I am 
married but this is the perception, that all Black men must have a big penis.’ (P4, 59) 
The particular needs of Black men and variability in provision were also seen as 
potentially contributing to inequalities.  
 
‘In order to get another size for your vacuum penile pump device, you have to pay for 
it and that’s a good point. I have to take another size as well and my GP was alright and he 
ordered a new one. So, the differences within the GP practices is that when I ask something 
to my GP he says yes and it is not a problem, but for many people could be a problem 
because the GPs say that you have to pay for it so it could an issue.  So, there is a real issue 
if you look at it as an after-care, you know what you can access, in terms of that this is a 
side-effect and you have to pay for it. That can’t be right.’ (P5, 75) 
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In spite of these limitations in GP knowledge and service provision, all agreed that they had 
never experienced any direct discrimination from healthcare professionals and believed they 
were treated similarly to any other patient. 
 
‘I didn’t experience any specific racist incidents. I can say that the guy who was 
dealing with me, he was good and I felt really comfortable, he told me that about the 
operation, that he is going to do the operation, he gave me his number and all that was very 
reassuring so for myself I can’t say that I felt any racist behaviour.’ (P7, 67) 
 
Discussion  
PCa is an arena in which masculinity and minority status intersect in ways that can 
influence the experience of discharge to primary care and the transition to survivorship.  
Masculine norms can affect men's response to PCa (e.g., Hoyt. Stanton, Irwin, and Thomas 
2013) and it is recognised that men from minority groups, both racial and sexual, have 
negative experiences of the healthcare system (e.g., Halbert et al. 2009; Eaton et al. 2015). 
In the present study, the experience of transitioning from hospital-based to primary care and 
subsequently to survivorship was shaped by the impact of treatment side-effects on 
masculine identity. This identity was located within a particular culturally determined framing 
of masculinity and interacted with systemic and structural processes of healthcare. 
The transition from secondary back to primary care was experienced as challenging 
and problematic in a number of ways.  Comments concerning the way in which discharge is 
frequently misunderstood as indicating that the disease has been cured demonstrate the 
impact of a perceived lack of clear and accurate information in preparing patients for 
discharge. Without this, the transition process is already potentially compromised, as the role 
of GPs will not be clearly understood. These men's interactions with GPs during the process 
of diagnosing cancer also played a role in shaping expectations about returning to their care.  
 
 
17 
 
Lack of knowledge among GPs of risk factors relevant to African-Caribbean men and a 
consequent failure to recommend or support PSA testing contributed to a lack of confidence 
in the ability of GPs to manage the side effects of treatment. Comments about the possible 
loss of notes, failures to send appointment reminders and lack of resources also indicated a 
lack of confidence in the ability of GP practices to provide adequate care.  Previous studies 
have shown that lack of trust in the healthcare system was one of the reasons why Black 
men did not see their doctor regularly (Metcalfe et al. 2008; Odedina et al. 2004). Our 
participants did not consider that they had been the victims of racist attitudes or values but 
they believed that lack of knowledge among GPs about aspects of PCa that were of 
particular relevance to the African-Caribbean community was problematic. This applied to all 
aspects of diagnosis and treatment, from awareness of risk factors, in particular, the elevated 
risk for African-Caribbean men, to appropriate advice and sensitivity relating to the 
management of social and sexual side-effects. The fact that both African-American and 
African-Caribbean men can develop PCa at a younger age and in a more aggressive form 
than White men means that they often experience side-effects such as ED at an age when 
sexual activity is still a significant aspect of their lives. Our participants believed that 
counselling and psychological support should be provided in relation to ED, but they were 
only able to obtain this support informally in the FAB group and not via their GP, who 
participants considered to be more focused on PSA testing than on their psychological 
welfare. The contrast between seeing familiar clinicians when attending hospital 
appointments and the lack of continuity of care in the GP practice was also a source of 
concern and they expressed reservations about raising sensitive topics with a GP who was 
unfamiliar to them.  Together with a perceived lack of relevant expertise among GPs, this led 
some men to opt for ongoing hospital-based care when given a choice. 
Participants described how culturally powerful and influential constructions of 
masculinity within their community rendered ED, and fear of ED, particularly salient. 
Perceptions of Black male identity that, in their view, foregrounded sexuality and penis size 
were seen as potential barriers to open communication with GPs. The complexities of both 
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recognising the importance of sexuality while managing difficulties at a personal level is 
apparent in distancing devices whereby "other" men are described as choosing death over 
the loss of sexual potency while participants also acknowledged a desire to return to how 
things were before surgery. Anderson et al. (2013) examined the experience of PCa among 
African and African-Caribbean men in the UK and found that fear of not being able to perform 
sexually after treatment was a major theme. Rivers and colleagues (2011) examined 
concerns about sexual functioning in African-American PCaSs and their wives and reported 
that for the male participants ED was perceived as the most important side-effect of 
treatment. The reduced sexual performance and desire were described as being key factors 
impacting their masculinity and manhood.  
Our participants felt constrained in relation to what they were able to share with their 
partners and children. They withheld information from them to avoid upsetting them and fears 
that their sons might, in turn, develop PCa led them to adopt a stoic demeanour in order to 
provide reassurance that both the disease and the side-effects of treatment could be 
managed. This is consistent with work by Hammond and Mattis (2005), who found that for 
African-American men masculinity was related to family leadership and the perception that 
they had to be a role model.  Emotional control and reluctance to seek help is also a 
component of the construct of hegemonic masculinity (Courtenay 2000). Non-disclosure of 
concerns, resulting in diminished support, may place Black men at risk of a greater 
psychological burden (Rivas et al. 2016), and our participants acknowledged this, which 
again emphasizes the need for adequate support and advice post-discharge. 
 
Clinical implications and future directions 
GP training should contain a greater focus on the needs of minority ethnic groups, 
specifically the risk factors and vulnerabilities of African-Caribbean men, regarding PCa. This 
could also be included in CPD courses in Urology. In a similar way, GPs and practice nurses 
need to be aware of sensitivities concerning help-seeking related to culturally-mediated 
understandings of masculinity, particularly in the area of sexuality.  
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Future studies should recruit a larger and nationally representative sample of African- 
Caribbean men. The perspectives of GPs in areas of diverse ethnicity and of GPs from 
African-Caribbean background would also be valuable in developing our understanding and 
knowledge of the issues identified in this study. 
 
Strengths and limitations 
Although the aim and the findings of this research are novel in the particular field of 
PCa and transition to primary care in the UK, some findings were consistent with those of 
previous relevant studies. This kind of triangulation suggests that the study was sufficiently 
sensitive and appropriately designed to enable it to identify issues that previous researchers 
had highlighted, such as side-effects and masculinity. While sexual orientation was not an 
inclusion or exclusion criterion, all the participants were heterosexual. Even though the aim 
of this study was not to achieve a statistical generalization of its findings, the challenges that 
participants described could be relevant to other cancer survivors or patients and could help 
the NHS to gain an insight into the problems and challenges concerning the process of 
discharge and survivorship in general. 
The researcher was self-reflective about her role and potential influence she may 
have had during the focus group and in the analysis process such as the identification of 
themes. 
The inclusion of quotes as representations and illustrations of each theme and sub-
theme provides a clear insight into the theme’s context and description. 
The men in this study may have been better informed about PCa than is typically the 
case and they benefitted from the support of a close-knit group of fellow survivors. All 
participants were recruited via the same support group. However, the use of a non-random 
and selective sample is common in qualitative approaches, which focus on identifying 
individuals who have lived specific experiences or have specific characteristics (Tuckett 
2003).  
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Conclusions 
The experience of discharge from secondary to primary/GP care can be anxiety-
provoking.  It seems likely that the issues described by our participants are not unique to 
African-Caribbean men and that the process overall needs to be made more clear and 
transparent, with explicit information about its meaning and what will happen next. African-
Caribbean PCaSs face many of the same challenges as all PCaSs. However, in their case, 
these are compounded by fears that their GPs do not fully understand the additional risk 
factors in this population and by particular assumptions concerning Black male sexuality 
among healthcare professionals as well as in wider society.  The role and position of men in 
African-Caribbean families is also an issue here. GPs and other primary healthcare providers 
would benefit from access to information and educational materials about the added burden 
of risk for African-Caribbean men as well as about their specific emotional and social needs. 
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